Corbus Pharmaceuticals Holdings, Inc.

US$3.07As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CRBPHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (32.93%)
Div yield —
ROE (95.58%)
Biotechnology
Beta (5Y) 2.79
PE TTM —
TSR TTM (74.73%)
Mkt cap US$59.38M
ROIC (60.74%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.04
(0.98%)
(54.09%)
Hold 7|9|3|12|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.06
0.07
0.07
0.06
24.96%
38.58%
24.42%
8.25%
Revenue$M
6.976
7.241
7.562
7.696
5.02%
6.91%
8.81%
11.66%
Peers (US$59.38M)
Cap (US$)
PE
59.98M
8.061x
59.76M
—
57.62M
—
59.29M
—
Capital
TTM
5Y
10Y
Leveragex
1.787
1.493
1.628
EBIT/Intx
0.721
0.071
0.073
Own earn%
720.00
161.08
146.36
Sh yield%
39.18
29.80
34.70
Owners
Insiders/Inst%
4.32
71.63
Short interest%
5.61
SBC / revenue%
5.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
6–16
$1 testx
−0.2
Incr. ROIC%
3